"How Blood Flow Restriction Exercise Affects Muscle Oxygenation and Lactate in Elite Athletes"
The Effect of Blood Flow Restriction Exercise on Muscle Oxygenation and Lactate Levels in Elite Athletes: A Comparative Study
1 other identifier
interventional
35
1 country
1
Brief Summary
This study investigates the effects of blood flow restriction (BFR) training combined with low-intensity aerobic exercise on muscle oxygenation, total hemoglobin (THb), and blood lactate levels in elite athletes, comparing them with healthy sedentary individuals. BFR training, which partially restricts arterial and fully restricts venous blood flow using a pneumatic cuff, creates a hypoxic environment, leading to muscle strength and endurance improvements with lower-intensity exercise. The study aims to determine whether BFR-induced occlusion enhances muscle adaptation and how these physiological responses differ between elite athletes and sedentary individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedFirst Submitted
Initial submission to the registry
March 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 19, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedApril 9, 2025
April 1, 2025
6 months
March 12, 2025
April 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in muscle oxygenation (SmO₂) measured by Moxy Muscle Oxygen Monitor (Near-Infrared Spectroscopy - NIRS)
Muscle oxygenation (SmO₂) will be assessed using the Moxy Muscle Oxygen Monitor, a validated NIRS-based device placed on the vastus lateralis muscle. Measurements will be taken pre- and post-exercise across multiple sessions to observe acute and cumulative responses.Unit of Measure: Percentage (%)
Over a period of 2 months
Change in blood lactate concentration measured by portable lactate analyzer (e.g., Lactate Scout+)
Capillary blood samples will be collected from the fingertip immediately before and 3 minutes after low-intensity aerobic exercise. Lactate levels will be analyzed using a validated point-of-care lactate analyzer to assess the metabolic response to BFR training.Unit of Measure: mmol/L
Immediately before and 3 minutes after each exercise session over a 2-month period
Change in body fat percentage measured by Bioelectrical Impedance Analysis (TANITA BIA device)
Body fat percentage will be assessed using a validated TANITA BIA device to evaluate changes in body composition.
Over a period of 2 months
Change in muscle mass measured by Bioelectrical Impedance Analysis (TANITA BIA device)
Muscle mass will be assessed using a TANITA BIA device to track training-induced adaptations. Unit of Measure: Kilograms (kg)
Baseline and end of 2-month intervention
Change in Body Mass Index (BMI) measured by Bioelectrical Impedance Analysis (TANITA BIA device)
BMI will be calculated from height and weight data provided by the TANITA BIA device to observe general body composition trends. Unit of Measure: kg/m²
Baseline and end of 2-month intervention
Study Arms (2)
Healthy Elite Male Athletes
EXPERIMENTALThese participants are physically inactive or engage in minimal physical activity. They do not follow a structured exercise regimen and have no history of professional or competitive sports participation. They are in good general health, with no chronic diseases or musculoskeletal disorders that could affect the study outcomes.
Healthy Sedentary Male Individuals
ACTIVE COMPARATORThese participants are actively involved in elite-level athletics, following a structured and high-intensity training program. They have extensive experience in competitive sports, particularly in track and field disciplines. They are in optimal physical condition, with well-developed cardiovascular and musculoskeletal systems, and no history of major injuries or health conditions that could impact their performance.
Interventions
The Blood Flow Restriction (BFR) intervention uses a pneumatic cuff to partially restrict arterial and fully restrict venous blood flow, creating a hypoxic environment that enhances muscle activation and strength at low exercise intensities. In this study, BFR will be applied intermittently during low-intensity treadmill walking with controlled pressure adjustments. The Moxy Muscle Oxygen Monitor is a non-invasive NIRS device that measures muscle oxygen saturation (SmO₂) and total hemoglobin (THb). Placed on the quadriceps femoris muscle, it will track oxygenation changes before, during, and after BFR exercise, helping assess muscle metabolism and performance adaptations.
Eligibility Criteria
You may qualify if:
- Willingness to participate in the study
- Male individuals aged 15-18 years
- Sedentary status for control group participants (\<600 MET-min/week according to the International Physical Activity Questionnaire - Short Form)
- Body mass index (BMI) \<25 kg/m²
- Licensed track and field athlete for the study group
- At least 3 years of experience as a licensed sprint athlete
- No history of sports injury in the last 6 months
You may not qualify if:
- Presence of open wounds or infection in the lower extremities
- Leg pain, varicose veins, or thrombophlebitis
- Diabetes or a history of cardiovascular disease
- Smoking and/or alcohol consumption
- Presence of respiratory distress
- Bilateral lower extremity pain and edema
- Incompatibility with the blood flow restriction (BFR) device
- Presence of diseases causing endothelial dysfunction (e.g., hypertension, cardiovascular diseases, neurological disorders, systemic inflammation, obesity, diabetes, atherosclerosis)
- History of deep vein thrombosis (DVT) or peripheral vascular disease
- Presence of acute infection
- History of cancer
- Surgical operation due to trauma within the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Burcin Ugur Tosun
Famagusta, 99010, Cyprus
Study Officials
- STUDY DIRECTOR
gulhan yılmaz gokmen, Assoc. Prof.
"Bandırma Onyedi Eylül University, Faculty of Health Sciences"
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Healthy Sedentary Male Individuals: These participants are physically inactive or engage in minimal physical activity. They do not follow a structured exercise regimen and have no history of professional or competitive sports participation. They are in good general health, with no chronic diseases or musculoskeletal disorders that could affect the study outcomes. Healthy Elite Male Athletes: These participants are actively involved in elite-level athletics, following a structured and high-intensity training program. They have extensive experience in competitive sports, particularly in track and field disciplines. They are in optimal physical condition, with well-developed cardiovascular and musculoskeletal systems, and no history of major injuries or health conditions that could impact their performance.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator PhD Physiotherapist Burcin Ugur Tosun
Study Record Dates
First Submitted
March 12, 2025
First Posted
April 9, 2025
Study Start
May 1, 2024
Primary Completion
October 15, 2024
Study Completion
March 19, 2025
Last Updated
April 9, 2025
Record last verified: 2025-04